<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Weber WP</dc:creator>
  <dc:creator>Morrow M</dc:creator>
  <dc:creator>Boniface J</dc:creator>
  <dc:creator>Pusic A</dc:creator>
  <dc:creator>Montagna G</dc:creator>
  <dc:creator>Kappos EA</dc:creator>
  <dc:creator>Ritter M</dc:creator>
  <dc:creator>Haug M</dc:creator>
  <dc:creator>Kurzeder C</dc:creator>
  <dc:creator>Saccilotto R</dc:creator>
  <dc:creator>Schulz A</dc:creator>
  <dc:creator>Benson J</dc:creator>
  <dc:creator>Fitzal F</dc:creator>
  <dc:creator>Matrai Z</dc:creator>
  <dc:creator>Shaw J</dc:creator>
  <dc:creator>Peeters MV</dc:creator>
  <dc:creator>Potter S</dc:creator>
  <dc:creator>Heil J</dc:creator>
  <dc:date>2020</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The aims of the Oncoplastic Breast Consortium initiative were to identify important knowledge gaps in the field of oncoplastic breast-conserving surgery and nipple-sparing or skin-sparing mastectomy with immediate breast reconstruction, and to recommend appropriate research strategies to address these gaps. A total of 212 surgeons and 26 patient advocates from 55 countries prioritised the 15 most important knowledge gaps from a list of 38 in two electronic Delphi rounds. An interdisciplinary panel of the Oncoplastic Breast Consortium consisting of 63 stakeholders from 20 countries obtained consensus during an in-person meeting to select seven of these 15 knowledge gaps as research priorities. Three key recommendations emerged from the meeting. First, the effect of oncoplastic breast-conserving surgery on quality of life and the optimal type and timing of reconstruction after nipple-sparing or skin-sparing mastectomy with planned radiotherapy should be addressed by prospective cohort studies at an international level. Second, the role of adjunctive mesh and the positioning of implants during implant-based breast reconstruction should ideally be investigated by randomised controlled trials of pragmatic design. Finally, the BREAST-Q questionnaire is a suitable tool to assess primary outcomes in these studies, but other metrics to measure patient-reported outcomes should be systematically evaluated and quality indicators of surgical morbidity should be further assessed.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/40026</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/S1470-2045(20)30084-X</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/32758475</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>The Lancet. Oncology. - 2020</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Breast Neoplasms</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Mammaplasty</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Knowledge gaps in oncoplastic breast surgery.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
